---
title: "Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission | CURX Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286420726.md"
description: "Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission | CURX Stock News"
datetime: "2026-05-14T04:55:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286420726.md)
  - [en](https://longbridge.com/en/news/286420726.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286420726.md)
generator: "portal-rs"
---

# Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission | CURX Stock News

Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission | CURX Stock News

### Related Stocks

- [CURX.US](https://longbridge.com/en/quote/CURX.US.md)

## Related News & Research

- [REG - UIL Limited UIL Finance Ltd - Purchase of 2026 ZDP Shares](https://longbridge.com/en/news/297937988.md)
- [18:24 ETBBNX Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Beta Bionics Inc.](https://longbridge.com/en/news/298235083.md)
- [Achieve Life Sciences highlights cytisinicline path to FDA approval, commercial launch in corporate presentation](https://longbridge.com/en/news/297831685.md)
- [REG - Morgan Stanley B.V. - ISM - MSBV - RETIREMENT - 03-09-2026](https://longbridge.com/en/news/297933660.md)
- [Endovia plans FDA pre-submission conference for CannEpil Z filing](https://longbridge.com/en/news/297517810.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**